| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |